| Records |
| Author |
United Nations Office on Drugs and Crime |
| Title |
World drug report 2011 |
Type |
Report |
| Year |
2011 |
Publication |
|
Abbreviated Journal |
|
| Volume |
|
Issue |
|
Pages |
267 |
| Keywords |
illicit drug; drug market; drug trafficking; addiction; chemical addiction; AOD dependence; AOD consumption; AOD demand; AOD supply; illegal production of drugs; illicit drug industry; search and seizure; law enforcement; statistical data; international area; annual report |
| Abstract |
Many illicit drug markets have reached global dimensions and require control strategies on a comparable scale. In that context, there is a need to better understand these transnational markets and the manner in which they operate. The yearly World Drug Report is a contribution towards that objective. This year’s edition starts with an overview of the illicit drug situation worldwide and regionally, followed by more comprehensive discussions and statistical trends for the key transnational drug markets, namely opium/heroin, coca/cocaine, amphetamine-type stimulants and cannabis. |
| Address |
|
| Corporate Author |
|
Thesis |
|
| Publisher |
United Nations Office on Drugs and Crime (UNODC) |
Place of Publication |
Vienna |
Editor |
|
Language  |
English |
Summary Language |
|
Original Title |
|
| Series Editor |
|
Series Title |
|
Abbreviated Series Title |
|
| Series Volume |
|
Series Issue |
|
Edition |
|
| ISSN |
|
ISBN |
|
Medium |
|
| Area |
|
Expedition |
|
Conference |
|
| Notes |
Executive summary also available: 50-11952; résumé aussi disponible en français: 50-11951 |
Approved |
no |
| Call Number |
50-11953 |
Serial |
50873 |
| Permanent link to this record |
| |
|
| |
| Author |
The Gallup Organization |
| Title |
Youth attitudes on drugs : analytical report |
Type |
Report |
| Year |
2011 |
Publication |
|
Abbreviated Journal |
|
| Volume |
|
Issue |
|
Pages |
59, annexes |
| Keywords |
survey; adolescent; attitude toward AOD; AOD consumption; illicit drug; drug market; internet; prevention campaign; school-based prevention; health; laws and regulations; European Union; Europe; report |
| Abstract |
|
| Address |
|
| Corporate Author |
|
Thesis |
|
| Publisher |
European Commission |
Place of Publication |
|
Editor |
Directorate General Justice of the European Commission |
| Language |
English |
Summary Language |
|
Original Title |
|
| Series Editor |
|
Series Title |
|
Abbreviated Series Title |
|
| Series Volume |
|
Series Issue |
|
Edition |
|
| ISSN |
|
ISBN |
|
Medium |
|
| Area |
|
Expedition |
|
Conference |
|
| Notes |
Summary of study also available: 50-11996 |
Approved |
no |
| Call Number |
50-11995 |
Serial |
50883 |
| Permanent link to this record |
| |
|
| |
| Author |
The Gallup Organization |
| Title |
Youth attitudes on drugs : analytical report : summary |
Type |
Report |
| Year |
2011 |
Publication |
|
Abbreviated Journal |
|
| Volume |
|
Issue |
|
Pages |
20 |
| Keywords |
survey; adolescent; attitude toward AOD; AOD consumption; illicit drug; drug market; internet; prevention campaign; school-based prevention; health; laws and regulations; European Union; Europe; report |
| Abstract |
|
| Address |
|
| Corporate Author |
|
Thesis |
|
| Publisher |
European Commission |
Place of Publication |
|
Editor |
Directorate General Justice of the European Commission |
| Language |
English |
Summary Language |
|
Original Title |
|
| Series Editor |
|
Series Title |
|
Abbreviated Series Title |
|
| Series Volume |
|
Series Issue |
|
Edition |
|
| ISSN |
|
ISBN |
|
Medium |
|
| Area |
|
Expedition |
|
Conference |
|
| Notes |
Full report also available: 50-11995 |
Approved |
no |
| Call Number |
50-11996 |
Serial |
50884 |
| Permanent link to this record |
| |
|
| |
| Author |
various |
| Title |
Further insights into aspects of the EU illicit drugs market : summaries and key findings |
Type |
Report |
| Year |
2013 |
Publication |
|
Abbreviated Journal |
|
| Volume |
|
Issue |
|
Pages |
43 |
| Keywords |
AOD use, abuse, and dependence; chemical addiction; illicit drug industry; drug market; treatment and maintenance; opioids in any form; drug substitution therapy; heroin; cannabis; public policy on AOD; drug decriminalization; AOD sales outlet; law enforcement; AOD price; cost (economic); international area; European Union; Europe; report |
| Abstract |
|
| Address |
|
| Corporate Author |
|
Thesis |
|
| Publisher |
Publications Office of the European Union; European Commission, Directorate General for Justice |
Place of Publication |
Luxembourg |
Editor |
Trautmann, Franz; Kilmer, Beau; Turnbull, Paul |
| Language |
English |
Summary Language |
|
Original Title |
|
| Series Editor |
|
Series Title |
|
Abbreviated Series Title |
|
| Series Volume |
|
Series Issue |
|
Edition |
|
| ISSN |
|
ISBN |
|
Medium |
|
| Area |
|
Expedition |
|
Conference |
|
| Notes |
|
Approved |
no |
| Call Number |
50-13030 |
Serial |
50885 |
| Permanent link to this record |
| |
|
| |
| Author |
European Monitoring Centre for Drugs and Drug Addiction |
| Title |
Pilot study on wholesale drug prices in Europe |
Type |
Report |
| Year |
2011 |
Publication |
|
Abbreviated Journal |
|
| Volume |
|
Issue |
|
Pages |
86 |
| Keywords |
drug; drug market; drug trafficking; statistical data; study; Europe; European Union |
| Abstract |
The European Union Drug Strategy for the period 2009–12 sets the goal to yield concrete and identifiable improvements concerning the knowledge of drugs trafficking. In addition, the EU Drugs Action Plan for 2009–12 defines among others the objectives to develop key-indicators of policy-relevant data on drug markets, as well as a strategy to collect them. This pilot study on wholesale drug markets aims to contribute to this process, starting by discussing the utility of collecting wholesale drug prices in Europe. In order to assess the feasibility of this collection process, this study provides an overview of the procedures implemented nationally and of the information available in European countries on wholesale drug prices. |
| Address |
|
| Corporate Author |
|
Thesis |
|
| Publisher |
European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) |
Place of Publication |
Lisbon |
Editor |
|
| Language |
English |
Summary Language |
|
Original Title |
|
| Series Editor |
|
Series Title |
|
Abbreviated Series Title |
|
| Series Volume |
|
Series Issue |
|
Edition |
|
| ISSN |
|
ISBN |
|
Medium |
|
| Area |
|
Expedition |
|
Conference |
|
| Notes |
|
Approved |
no |
| Call Number |
50-12093 |
Serial |
50899 |
| Permanent link to this record |
| |
|
| |
| Author |
United Nations Office on Drugs and Crime |
| Title |
Amphetamines and ecstasy |
Type |
Report |
| Year |
2011 |
Publication |
|
Abbreviated Journal |
|
| Volume |
|
Issue |
|
Pages |
120 |
| Keywords |
illicit drug; drug market; drug trafficking; addiction; chemical addiction; AOD dependence; AOD consumption; AOD demand; AOD supply; illegal production of drugs; illicit drug industry; amphetamines; ecstasy |
| Abstract |
Three years after the last global assessment of Amphetamine-Type Stimulants (ATS), the manufacture and trafficking of these drugs remains a serious and constantly evolving challenge. The 2011 Global ATS Assessment shines a powerful light on ATS helping governments to better understand this important phenomenon. Once viewed as purely a cottage industry, ATS manufacture and trafficking has undergone its own industrial revolution. After cannabis, ATS are the second most widely used drugs across the globe outstripping the use of heroin or cocaine. ATS are now manufactured and marketed with organized crime groups involved throughout the production and supply chain. Until recently, the ATS trade was sometimes ignored in favour of the traditional focus on heroin and cocaine. But there is growing recognition that the expansion of the ATS trade and its high profits threaten security, health and the welfare of populations across the globe. [...] |
| Address |
|
| Corporate Author |
|
Thesis |
|
| Publisher |
United Nations Office on Drugs and Crime (UNODC) |
Place of Publication |
Vienna |
Editor |
|
| Language |
English |
Summary Language |
|
Original Title |
|
| Series Editor |
|
Series Title |
|
Abbreviated Series Title |
|
| Series Volume |
|
Series Issue |
|
Edition |
|
| ISSN |
|
ISBN |
|
Medium |
|
| Area |
|
Expedition |
|
Conference |
|
| Notes |
|
Approved |
no |
| Call Number |
50-12137 |
Serial |
50901 |
| Permanent link to this record |
| |
|
| |
| Author |
WHO Regional Committee for Europe |
| Title |
European action plan to reduce the harmful use of alcohol 2012-2020 |
Type |
Report |
| Year |
2011 |
Publication |
|
Abbreviated Journal |
|
| Volume |
|
Issue |
|
Pages |
25 |
| Keywords |
alcohol; health care costs; harm reduction; conference; advertisement; advertising ban; alcohol intoxication; laws and regulations; Europe |
| Abstract |
|
| Address |
|
| Corporate Author |
|
Thesis |
|
| Publisher |
World Health Organization (WHO), Regional Office for Europe |
Place of Publication |
Copenhagen |
Editor |
|
| Language |
English |
Summary Language |
|
Original Title |
|
| Series Editor |
|
Series Title |
|
Abbreviated Series Title |
|
| Series Volume |
|
Series Issue |
|
Edition |
|
| ISSN |
|
ISBN |
|
Medium |
|
| Area |
|
Expedition |
|
Conference |
|
| Notes |
Auch auf Deutsch vorhanden: 50-12140; aussi disponible en français: 50-12141 |
Approved |
no |
| Call Number |
50-12142 |
Serial |
50904 |
| Permanent link to this record |
| |
|
| |
| Author |
European Monitoring Centre for Drugs and Drug Addiction |
| Title |
Annual report 2011 : the state of the drugs problem in Europe |
Type |
Report |
| Year |
2011 |
Publication |
|
Abbreviated Journal |
|
| Volume |
|
Issue |
|
Pages |
105 |
| Keywords |
AOD public policy strategy; public policy on illicit drugs; other drug laws; cannabis; MDMA; ecstasy; LSD; cocaine; crack cocaine; intravenous injection; opioids in any form; piperazine; ketamine; gamma-hydroxybutyric acid; communicable disease; AODR mortality; mephedrone; Europe; annual report |
| Abstract |
The report on the state of the drugs problem in Europe presents the EMCDDA’s yearly overview of the drug phenomenon. This is an essential reference book for policy-makers, specialists and practitioners in the drugs field or indeed anyone seeking the latest findings on drugs in Europe. Published every autumn, the report contains non-confidential data supported by an extensive range of figures. |
| Address |
|
| Corporate Author |
|
Thesis |
|
| Publisher |
Publications Office of the European Union |
Place of Publication |
Luxembourg |
Editor |
|
| Language |
English |
Summary Language |
|
Original Title |
|
| Series Editor |
|
Series Title |
Annual report |
Abbreviated Series Title |
|
| Series Volume |
|
Series Issue |
|
Edition |
|
| ISSN |
1609-6150 |
ISBN |
978-92-9168-470-0 |
Medium |
|
| Area |
|
Expedition |
|
Conference |
|
| Notes |
Auch auf Deutsch vorhanden: 50-12171; aussi disponible en français: 50-12172; anche disponibile in italiano: 50-12173 |
Approved |
no |
| Call Number |
50-12174 |
Serial |
50910 |
| Permanent link to this record |
| |
|
| |
| Author |
European Monitoring Centre for Drugs and Drug Addiction |
| Title |
Cost and financing of drug treatment services in Europe : an exploratory study |
Type |
Report |
| Year |
2011 |
Publication |
|
Abbreviated Journal |
|
| Volume |
|
Issue |
|
Pages |
23 |
| Keywords |
Aod; AOD use, abuse, and dependence; addiction; heroin; treatment and maintenance; detoxification; inpatient care; outpatient care; methadone; heroin-assisted treatment; financial management; treatment cost; treatment method; financial statement; financing; study; Europe; report |
| Abstract |
Recent estimates suggest that, each year, over 1 million Europeans receive treatment for problems related to the use of illicit drugs (EMCDDA, 2010). Of these, more than half receive opioid substitution treatment for problems related to opioid drugs, primarily heroin. The current levels of provision of drug treatment services in the European Union are the result of an expansion of services that has taken place during the last two decades. For much of that time, services expanded against a background of a growing drug problem, and one in which economic conditions were largely favourable. Now, however, in an era of cuts in government expenditure, managing the costs of treatment and ensuring the highest quality and best outcomes for the lowest possible cost are priorities. While measuring and improving drug treatment outcomes have been relatively high on the research agenda in recent years, the cost of treatment has received far less research attention. Addressing this information gap is likely to have a number of benefi ts for both decision-makers and treatment providers. On the one hand, service providers need accurate information on the costs of service provision in order to plan the allocation of resources. On the other, decision-makers and funders can use such information as a means of cost control, for example, by comparing costs of similar services or those of alternative providers of similar services. Finally, as a part of a fuller economic analysis, information on service costs is needed to determine the cost-effectiveness of interventions and treatment programmes. The cost of drug treatment in Europe is looked at from two main angles in this Selected issue. First, it presents an overview of the main sources of drug treatment funding and the financing mechanisms that are employed in European countries. The available data are presented on who is paying for drug treatment, how funding is organised, and how funding is distributed among different treatment modalities. This is followed by an analysis of the unit costs of different types of drug treatment. Costs related to opioid substitution treatment including the costs of substitution medication for a number of European countries are presented here. This publication keeps a tight focus on the cost of drug treatment and does not attempt to undertake a broader economic analysis of the healthcare and social costs relating to illicit drugs. This Selected issue represents a fi rst attempt to provide a European overview of drug treatment costs, and individual countries are brought into focus to illustrate specifi c aspects of the analysis. This subject is both topical and methodologically challenging. The varying availability of information as well as the complexity of funding arrangements mean that, at best, only very incomplete estimates can be made of the costs of (or expenditure on) drug treatment in Europe. |
| Address |
|
| Corporate Author |
|
Thesis |
|
| Publisher |
Publications Office of the European Union |
Place of Publication |
Luxembourg |
Editor |
|
| Language |
English |
Summary Language |
|
Original Title |
|
| Series Editor |
|
Series Title |
Selected issues |
Abbreviated Series Title |
|
| Series Volume |
|
Series Issue |
|
Edition |
|
| ISSN |
1830-7957 |
ISBN |
978-92-9168-464-9 |
Medium |
|
| Area |
|
Expedition |
|
Conference |
|
| Notes |
|
Approved |
no |
| Call Number |
50-12180 |
Serial |
50911 |
| Permanent link to this record |
| |
|
| |
| Author |
European Monitoring Centre for Drugs and Drug Addiction |
| Title |
Mortality related to drug in Europe : public health implications |
Type |
Report |
| Year |
2011 |
Publication |
|
Abbreviated Journal |
|
| Volume |
|
Issue |
|
Pages |
33 |
| Keywords |
Aod; AOD use, abuse, and dependence; addiction; illicit drug; heroin; morbidity; AOD overdose; AODR mortality; prevalence; Europe; report |
| Abstract |
In recent decades, the overall level of illicit drug use in Europe has risen dramatically, and with it the number of deaths among the drug-using population, in particular among problem drug users. In the 21st century, a considerable share of premature or avoidable mortality among young adults can be attributed to illicit drug overdose, which accounts for an estimated 4% of deaths among those aged 15–39 in Europe (1). These deaths are often related to injecting drug use and, in most cases, involve a combination of substances (Best et al., 2000), but they represent only part of mortality among drug users (2). In addition, a substantial number of deaths are indirectly related to drug use, such as those from HIV/AIDS related to injecting drug use, accidents, violence and suicides. The high levels of mortality among drug users are a serious cause for concern both at the individual and the societal level. The number of problem opioid users in Europe is cautiously estimated at about 1.3 million (3), and it is among these opioid users, particularly injectors, that we find the greatest share of morbidity and mortality related to illicit drug use in Europe. Heroin is the drug most often associated with overdose, although other drugs and alcohol are commonly present. Overdose represents a major cause of avoidable death associated with illicit drug use, and from 1990 to 2010, between 6 500 and 8 500 overdose deaths have |
| Address |
|
| Corporate Author |
|
Thesis |
|
| Publisher |
Publications Office of the European Union |
Place of Publication |
Luxembourg |
Editor |
European Monitoring Centre for Drugs and Drug Addiction |
| Language |
English |
Summary Language |
|
Original Title |
|
| Series Editor |
|
Series Title |
|
Abbreviated Series Title |
|
| Series Volume |
|
Series Issue |
|
Edition |
|
| ISSN |
|
ISBN |
|
Medium |
|
| Area |
|
Expedition |
|
Conference |
|
| Notes |
|
Approved |
no |
| Call Number |
50-12181 |
Serial |
50912 |
| Permanent link to this record |
